cytori
-
Hospitals
Cytori Cell Therapy Receives Limited Approval for Osteoarthritis in Japan
June 27, 2016 SAN DIEGO & TOKYO–(BUSINESS WIRE)–Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced that the use of Cytori…
Read More » -
Sports Medicine
Presentation of Twelve Month Pilot Trial Data of Cytori® Cell Therapy™ for ACL Reconstruction
SAN DIEGO–(BUSINESS WIRE)–Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today Dr. Ramón Cugat MD, Ph.D. will present 12-month follow-up results from…
Read More » -
Sports Medicine
Enrollment Begins European Knee Meniscus Injury Pilot Trial to Evaluate Cytori Cell Therapy
SAN DIEGO–(BUSINESS WIRE)–Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that the first patient was enrolled and treated this week in…
Read More » -
Sports Medicine
Cytori Announces Promising Results in a Feasibility Trial of Cytori Cell Therapy in Conjunction with Anterior Cruciate Ligament Repair
Cell Therapy in ACL Surgery May Provide Quicker Recovery in BPTB Transplantation SAN DIEGO–(BUSINESS WIRE)– Cytori Therapeutics, Inc. (NASDAQ: CYTX)…
Read More » -
Cytori Issued Celution(R) System Patent for Orthopedic & Spinal Disc Diseases
SAN DIEGO, Aug 12, 2010 (BUSINESS WIRE) — Cytori Therapeutics (CYTX 4.69, +0.13, +2.88%) has received U.S. Patent No. 7,771,716 (the ‘716 patent) for…
Read More » -
Cytori Therapeutics wins new Celution system patent for spinal disc disease
Cytori Therapeutics, a developer of medical products and devices, has received USpatent for Celution system based methods of treating musculoskeletal…
Read More »